Home / Business and Economy / CSL Taps GSK Veteran Waterhouse for CEO Role
CSL Taps GSK Veteran Waterhouse for CEO Role
22 Oct
Summary
- Deborah Waterhouse appointed as CSL's new CEO.
- Waterhouse brings extensive experience from ViiV Healthcare.
- Her appointment aims to steer CSL through a company turnaround.
Australian biotech firm CSL Ltd. has named Deborah Waterhouse as its next chief executive officer and managing director. Waterhouse brings a wealth of experience to the role, having previously led ViiV Healthcare, a company focused on HIV drugs and backed by GSK PLC.
Her appointment comes at a pivotal time for CSL, as the company seeks a turnaround. Waterhouse's proven track record in the pharmaceutical industry is anticipated to be instrumental in guiding CSL through its current challenges and towards future growth.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
